Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Patent
1995-09-15
1998-11-10
Cunningham, Thomas M.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
4241921, 4242301, 530350, 536 234, A61K 3912, C07K 1405, C07H 2104
Patent
active
058339914
ABSTRACT:
The invention provides compositions and methods for preventing undesired immune responses in which a recombinant protein is prepared which includes a glycine-containing amino acid sequence, protein substantial invisibility to the immune system.
REFERENCES:
Hummel et al. Virology 148: 337 1986.
Bourdon et al PNAS 82: 1321, 1985.
Condit et al. Nature 323:178, 1986.
Levitskaya et al., Nature 375:685-688 (1995).
Cobra Therapeutics, Ltd.
Cunningham Thomas M.
Lubet Martha
Williams Kathleen M.
LandOfFree
Glycine-containing sequences conferring invisibility to the immu does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glycine-containing sequences conferring invisibility to the immu, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glycine-containing sequences conferring invisibility to the immu will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1514137